Xestospongins: Potent membrane permeable blockers of the inositol 1,4,5- trisphosphate receptor

Neuron

Volumn 19, Issue 3, 1997, Pages 723-733

  Gafni, Juliette ^c   Munsch, Julia A ^a   Lam, Tien H ^c   Catlin, Michelle C ^b   Costa, Lucio G ^b   Molinski, Tadeusz F ^a   Pessah, Isaac N ^c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

BRADYKININ; CAFFEINE; CALCIUM ION; CARBACHOL; DYE; INOSITOL 1,4,5 TRISPHOSPHATE; INOSITOL 1,4,5 TRISPHOSPHATE RECEPTOR; QUINOLIZIDINE DERIVATIVE; RYANODINE; RYANODINE RECEPTOR; UNCLASSIFIED DRUG; XESTOSPONGIN A;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BINDING SITE; BRAIN MICROSOME; CALCIUM TRANSPORT; CEREBELLUM; CONTROLLED STUDY; CYTOTOXICITY; ENDOPLASMIC RETICULUM; FLUORESCENCE MICROSCOPY; MALE; MEMBRANE VESICLE; NONHUMAN; PHEOCHROMOCYTOMA CELL; PRIORITY JOURNAL; RABBIT; RAT; STRUCTURE ACTIVITY RELATION;

EID: 0030964614     PISSN: 08966273     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-6273(00)80384-0     Document Type: Article

References (46)

1. Arrang, J.M. (1994). Pharmacological properties of histamine receptor subtypes. Cell. Mol. Biol. 40, 275-281.
2. Berridge, M.J. (1993). Inositol trisphosphate and calcium signaling. Nature 361, 315-325.
3. Bezprozvanny, I.B., Ondrias K., Kaftan E., Stoyanovsky D.A., and Ehrlich, B.E. (1993). Activation of the calcium release channel (ryanodine receptor) by heparin and other polyanions is calcium dependent. Mol. Biol. Cell 4, 347-352.
4. Brann, M.R., Klimkowski, V.J., and Ellis, J. (1993). Structure/function relationships of muscarinic acetylcholine receptors. Life Sci. 52, 405-412.
5. Bretschneider, E., Paintz, M., and Glusa, E. (1995a). Inositol 1, 4, 5-trisphosphate and protein kinase C are involved in thrombin-and trap-induced vascular smooth muscle contraction. Agents Actions Suppl. 45, 309-313.
6. Bretschneider, E., Paintz, M., and Glusa, E. (1995b). Involvement of inositol 1, 4, 5-trisphosphate and protein kinase C in thrombininduced contraction of porcine ulmonary artery. Biochem. Pharmacol. 49, 33-38.
7. Briner, V.A., Tsai, P., and Schrier, R.W. (1993). Bradykinin: potential for vascular constriction in the presence of endothelial injury. Am. J. Physiol. 264, F322-F327.
8. Cameron, A.M., Steiner, J.P., Sabatini, D.M., Kaplin, A.I., Walensky, L.D., and Snyder, S.H. (1995). Immunophilin FK506-binding protein associated with inositol 1,4,5-trisphosphate receptor modulates calcium flux. Proc. Natl. Acad. Sci. USA 92, 1784-1788.
9. Crews, P., Slate, D.L., Gerwick, W.H., Schmitz, F.J., Scatzman, R., Strulovici, B., Cannon, P., and Hunter, L.M. (1994). Screening for anticancer leads from marine organisms in a mechanism-based drug delivery program. Dev. Oncol. 74, 364-403.
10. Dauphin, F., Linville, D.G., and Hamel, E. (1994). Cholinergic dilatation and constriction of feline cerebral blood vessels are mediated by stimulation of phosphoinositide metabolism via two different muscarinic receptor subtypes. J. Neurochem. 63, 544-551.
11. Endo, M., Nakagawa, M., Hamamoto, Y., and Ishihama, M. (1986). Pharmacologically active substances from southern Pacific marine invertebrates. Pure Appl. Chem. 58, 387-394.
12. 2+ pools in PC12 cells. J. Biol. Chem. 266, 20159-20167.
13. Furuichi, T., Yoshikawa, S., Miyawaki, A., Wada, K., Maeda, N., and Mikoshiba, K. (1989). Primary structure and functional expression of the inositol 1,4,5-trisphosphate-binding protein P400. Nature 342, 32-38.
14. Ghosh, T.K., Eis, P.S., Mullaney, J.M., Ebert, C.L., and Gill, D.L. (1988). Competitive, reversible, and potent antagonism of inositol 1,4,5-trisphosphate-activated calcium release by heparin. J. Biol. Chem. 263, 11075-11079.
15. i effects of bradykinin B2 receptor activation in PC12 cells. Agents Actions. Suppl. 38, 9-15.
16. Guizzetti, M., Costa, M., Peters, J., and Costa, L.G. (1996). Acetylcholine as a mitogen: muscarinic receptor-mediated proliferation of rat astrocytes and human astrocytoma cells. Eur. J. Pharmacol. 297, 265-273.
17. Harnick, D.J., Jayaraman, T., Ma, Y., Mulieri, P., Go, L.O., and Marks, A.R. (1995). The human type 1 inositol 1,4,5-trisphosphate receptor from T lymphocytes. Structure, localization, and tyrosine phosphorylation. J. Biol. Chem. 270, 2833-2840.
18. Hoye, T.R., North, J.T., and Yao, L.J. (1994). Conformational considerations in 1-oxaquinolizidines related to the xestospongin/araguspongine family: reassignment of stereostructures for araguspongines B and E. J. Org. Chem. 59, 6904-6910.
19. Hoye, T.R., North, J.T., and Yao, L.J. (1995). Conformational considerations in 1-oxaquinolizidines related to the xestospongin/araguspongine family: reassignment of stereostructures for araguspongines B and E. J. Org. Chem. 60, 4958.
20. Kitagawa, I., Kobayashi, M., and Kawazoe, K. (1989). Araguspongines B, C, D, E, F, G, H, and J, new vasodilative bis-1-oxaquinolizidine alkaloids from an okinawan marine sponge, Xestospongia sp. Chem. Pharm. Bull. (Tokyo) 37, 1676-1678.
21. Kobayashi, S., Somlyo, A.V., and Somlyo, A.P. (1988). Heparin inhibits the inositol 1,4,5-trisphosphate-dependent, but not the independent, calcium release induced by guanine nucleotide in vascular smooth muscle. Biochem. Biophys. Res. Commun. 153, 625-631.
22. Kovacs, K.A., Kavanagh, T.J., and Costa, L.G. (1995). Ethanol inhibits muscarinic receptor-stimulated phosphoinositide metabolism and calcium mobilization in rat primary cortical cultures. Neurochem. Res. 20, 939-949.
23. Lowry, O.H., Rosebrough, N.J., Farr, A.L., and Randall, R.J. (1951). Protein measurement with folin phenol reagent. J. Biol. Chem. 193, 265-275.
24. Maranto, A.R. (1994). Primary structure, ligand binding, and localization of the human type 3 inositol 1,4,5-trisphosphate receptor expressed in intestinal epithelium. J. Biol. Chem. 269, 1222-1230.
25. Marks, A.R. (1996). Cellular functions of immunophilins. Physiol. Rev. 76, 631-649.
26. McCarthy, K.D., and De Vellis, J. (1980). Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue. J. Biol. Chem. 85, 890-902.
27. Mignery, G.A., Südhof, T.C., Takei, K., and De Camilli, P. (1989). Putative receptor for inositol 1,4,5-trisphosphate similar to ryanodine receptor. Nature 342, 192-195.
28. Mignery, G.A., Newton, C.L., Archer, B.T.d., and Südhof, T.C. (1990). Structure and expression of the rat inositol 1,4,5-trisphosphate receptor. J. Biol. Chem. 265, 12679-12685.
29. Mohr, F.C., Hershey, P.E., Zimanyi, I., and Pessah, I.N. (1993). Regulation of inositol 1,4,5-trisphosphate receptors in rat basophilic leukemia cells. I. Multiple conformational states of the receptor in a microsomal preparation. Biochem. Biophys. Acta 1147, 105-114.
30. 2+ release analysed using region-specific monoclonal antibodies. Biochem. J. 277, 125-131.
31. Nakagawa, M., Endo, M., Tanaka, N., and Gen-Pei, L. (1984). Structures of xestospongin A, B, C and D, novel vasodilative compounds from marine sponge, Xestospongia exigua. Tetrahedron Lett. 25, 3227-3230.
32. Nakanishi, S., Maeda, N., and Mikoshiba, K. (1991). Immunohistochemical localization of an inositol 1,4,5-trisphosphate receptor, P400, in neural tissue: studies in developing and adult mouse brain. J. Neurosci. 11, 2075-2086.
33. 2+, caffeine, and adenine nucleotides. Mol. Pharmacol. 31, 232-238.
34. 3H1 cells. Am. J. Physiol. 272, C601-C614.
35. Pettit, G.R., Orr, B., Herald, D.L., Doubek, D.L., Tackett, L., Schmidt, J.M., Boyd, M.R., Pettit, R.K., and Hooper, J.N.A. (1996). Isolation and x-ray crystal structure of racemic xestospongin D from the Singapore marine sponge Niphates sp. Bioorg. Med. Chem. Lett. 6, 1313-1318.
36. Pin, J.-P., and Duvoisin, R. (1995). Review: neurotransmitter receptors I-the metabotropic glutamate receptors: structure and functions. Neuropharmacology 34, 1-26.
37. Quirion, J.C., Sevenet. T., Husson, H.P., Weniger, B., and Debitus, C. (1992). Two new alkaloids from Xestospongia sp., a new Caledonian sponge. J. Nat. Prod. 55, 1505-1508.
38. Ross, C.A., Danoff, S.K., Schell, M.J., Snyder, S.H., and Ullrich, A. (1992). Three additional inositol 1,4,5-trisphosphate receptors: molecular cloning and differential localization in brain and peripheral tissues. Proc. Natl. Acad. Sci. USA 89, 4265-4269.
39. Saito, A., Seiler, S., Chu, A., and Fleischer, S. (1984). Preparation and morphology of sarcoplasmic reticulum terminal cisternae from rabbit skeletal muscle. J. Cell Biol. 99, 875-885.
40. 3 receptor. EMBO J. 10, 3199-3206.
41. Sullivan, K.M., Lin, D.D., Agnew, W., and Wilson, K.L. (1995). Inhibition of nuclear vesicle fusion by antibodies that block activation of inositol 1,4,5-trisphosphate receptors. Proc. Natl. Acad. Sci. USA 92, 8611-8615.
42. Takeshima, H., Nishimura, S., Matsumoto, T., Ishida, H., Kangawa, K., Minamino, N., Matsuo, H., Ueda, M., Hanaoka, M., Hirose, T., et al. (1989). Primary structure and expression from complementary DNA of skeletal muscle ryanodine receptor. Nature 339, 439-445.
43. Tinker, A., and Williams, A.J. (1995). Measuring the length of the pore of the sheep cardiac reticulum calcium-release channel using related molecular calipers. Biophys. J. 68, 111-120.
44. Verma, A., Ross, C.A., Verma, D., Supattapone, S., and Snyder, S.H. (1990). Rat brain endoplasmic reticulum calcium pools are functionally segregated. Cell Regul. 1, 781-790.
45. 3R1: structure, function, regulation of expression and chromosomal localization. Biochem. J. 302, 781-790.
46. 2+ pools in PC12 cells. J. Biol. Chem. 266, 20152-20158.